BioLife Solutions, Inc. provided revenue guidance for 2022. Total revenue for 2022 is expected to range from $159.5 million to $171.0 million, reflecting year-over-year growth of 34% to 44% and organic growth of 28% to 39%. COVID-19 related revenue is expected to account for approximately 8% to 9% of total revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.2 USD | -1.66% | -0.49% | +24.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.31% | 931M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+2.58% | 41.61B | |
+19.93% | 31.07B | |
+11.40% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- BLFS Stock
- News BioLife Solutions, Inc.
- BioLife Solutions, Inc. Provides Revenue Guidance for 2022